Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GPCR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
GPCR stock price ended at $23.74 on Friday, after rising0.38%
The Structure Therapeutics Inc stock price increased by 0.38% on the last trading day (Friday Apr 2025), rising from 23.5 to 23.74. Throughout the last trading session, the stock experienced a fluctuation of 4.28% , ranging from a day low of $23.1987 to a day high of 24.1912. The price has declined in 3 of the last 10 days, resulting in a total change of 57.74% during this period. On the last day, trading volume decrease by 3.22K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 731.80K shares were traded, amounting to approximately 17.38M.
GPCR Technical Signals
GPCR(Structure Therapeutics Inc Corp) has 3 buy signals and 4 sell signals now. The current trend is downtrend starting from 2025-02-28. The total price change during this trend is -0.04%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of GPCR over the last 5 trading days is 26.60M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
GPCR Moving Average Analysis
Structure Therapeutics Inc's overall moving average trend leans more bullish as of Monday, April 28, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $26.02, and $29.63. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $14.34, and $10.73. A break-down below any of these levels will issue sell signals.
GPCR Short Selling Analysis
The short sale ratio of Structure Therapeutics Inc(GPCR) as of 25 Apr 2025 is 20.49%, dropping from last trading day. With decreasing price from 23.65 to 23.74. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
4
Buy
3
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
3.6
Bullish
Momentum (10 days)
MOM_10 > 0
8.69
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.85
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
92.16
Bearish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
121.27
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
100
Bearish
Williams %R (14 days)
WILLR_14 > -20
-6.32
Bearish
GPCR Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Structure Therapeutics Inc(GPCR), our algorithm predicts GPCR's 1-month price at $21.00, with an -11.53%downwardshift. Using a similarity score up to 96.66%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Structure Therapeutics Inc (GPCR.O) stock, as of Sunday, April 27, 2025 , forecasts a -11.53% change over the next month, based on its high correlation with CDXS.O stock patterns. The similarity between their price movements over the analyzed periods is 96.66%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
GPCR
CDXS
Down: -11.53%Similarity: 96.66%
Name
Similarity
Up/Down
No Data
GPCR Seasonality Analysis
Based on GPCR's historical stock price data across all years, the probability of a positive return in April is66.67%, suggesting it maybe an ideal month to invest in GPCR. In contrast,offers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Structure Therapeutics Inc (GPCR.O) stock in January has the highest probability of a positive return (100.00%), while February has the lowest probability (0.00%).
Performance Seasonality
The chart shows Structure Therapeutics Inc. (GPCR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Structure Therapeutics Inc (GPCR.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GPCR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Structure Therapeutics Inc (GPCR.O) stock in a year?
The radar chart shows that buying Structure Therapeutics Inc (GPCR.O) stock in January has the highest probability of a positive return (100.00%), while February has the lowest probability (0.00%).
How has Structure Therapeutics Inc. (GPCR)'s stock price performed over the past three years?
GPCR's stock price rose by 56.77% in 2023,decreased by -32.85% in 2024, and went down by 15.79% in 2025.
Is GPCR a buy based on overall technical signals summary?
GPCR has 3 buy signals and 4 sell signals now. Overall the technical rating for GPCR is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of GPCR.
What is the trend of Structure Therapeutics Inc (GPCR)'s moving average?
Structure Therapeutics Inc's overall moving average trend leans more bullish as of April 28 2025, with 2 negative signals and 2 positive signal.
What is price prediction for GPCR stock next month?
The price prediction chart for Structure Therapeutics Inc (GPCR.O) stock, as of April 27 2025, forecasts a -11.53% change over the next month, based on its high correlation with CDXS stock patterns. The similarity between their price movements over the analyzed periods is 96.66%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for GPCR Stock?
The price prediction for GPCR stock in 2025 is **$29.01**. This target is based on Fibonacci resistance levels and positive momentum from recent news about Eli Lilly's Phase 3 results.
What is price prediction 2030 for GPCR Stock?
### **Price Prediction for GPCR Stock by 2030**
Based on current trends and analysis, here is a concise price prediction for GPCR stock by 2030:
1. **Predicted Price Range**:
- **Low Estimate**: $25
- **Base Estimate**: $35
- **High Estimate**: $50
2. **Reasoning**:
- **Positive Momentum**: GPCR has shown strong gains recently, driven by positive developments in its oral GLP-1 agonist for obesity, similar to Eli Lilly's success.
- **Analyst Expectations**: Analysts anticipate significant weight loss results from GPCR's upcoming trials, which could drive further growth.
- **Market Potential**: The growing demand for obesity treatments positions GPCR well for long-term growth.